| |
|
|
|
Tenax Therapeutics Inc.  
|
|
1.42 0.03 (0.02%) |
07-15 16:00 |
|
Open: |
1.4056 |
Pre close: |
1.39 |
Target:
|
1.81
|
|
High: |
1.45 |
Low: |
1.38 |
Resistance:
|
1.55
1.81
|
|
Volume: |
77,151 |
Market Cap: |
9M |
Support:
|
1.34
1.21
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.40
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
1.34 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
1.54 |
Stochastic Oscillator |
%K(14,3):
|
70.58  |
|
MA(250): |
2.88 |
%D(3): |
69.56 |
|
Average Volume(K) |
3-Month: |
12252
|
52-Week |
High:
|
6.94 |
|
10-Days: |
5128 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
56.33 |
Change(%): |
-78.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.993 |
Return on Equity (ttm) |
-78.9 |
Shares Out. (M) |
6.19 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-46.2 |
Shares Float (M) |
6.16 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.73 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.31 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
752 |
|
Book Value (p.s.) |
1.680 |
EBITDA (p.s.) |
-1.178 |
P/E |
-0.24 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.85 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.07 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.62 |
P/CF |
-1.45 |
|
|
|
|
|
|
